Comparison of insulin resistance and lipid profile in clinically significant macular oedema versus non-clinically significant macular oedema in patients with type 2 diabetes mellitus
DOI:
https://doi.org/10.63341/ijmmr/1.2025.22Keywords:
diabetic macular oedema, dyslipidaemia, retinal diseases, diabetic neuropathies, retinal vein occlusionAbstract
Lifestyle-related disorders, particularly diabetes, pose a significant global health challenge. Diabetic macular oedema, a microvascular complication, highlights the importance of managing insulin resistance and hyperlipidaemia for optimal clinical outcomes. Understanding the interplay between these factors is crucial for optimising therapeutic strategies and improving patient care. This cross-sectional study aimed to compare insulin resistance and lipid profiles between patients with clinically significant macular oedema and those with non-clinically significant macular oedema, both diagnosed with type 2 diabetes mellitus. This research can aid in the earlier identification and classification of macular oedema, enabling more timely and specific interventions. In general, 86 patients with type 2 diabetes mellitus and macular oedema were divided into two groups: clinically significant macular oedema and non-clinically significant macular oedema. Comprehensive demographic data, medical histories, and current medication regimens were recorded. Glycaemic control and lipid profiles were assessed, while ophthalmological evaluations included visual acuity measurements and intraocular pressure assessments. Significant differences were observed between the two groups, particularly in diabetes duration, body mass index, blood glucose levels, and lipid profiles. Patients with clinically significant macular oedema had a longer duration of diabetes, a higher body mass index, and elevated blood glucose levels. Triglyceride levels were significantly higher, while high density lipoprotein levels were lower in the clinically significant macular oedema group. Multivariate analysis revealed significant associations between the odds of developing clinically significant macular oedema and diabetes duration, visual acuity, and high-density lipoprotein
levels, suggesting their potential as risk factors for this condition
Received: 18.10.2024 | Revised: 23.03.2025 | Accepted: 27.05.2025
References
GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with
projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet.
;402(10397):203–34. DOI: 10.1016/S0140-6736(23)01301-6
International Diabetes Federation (IDF) Diabetes Atlas [Internet]. [cited 2024 October 8]. Available from: https://
diabetesatlas.org/atlas/tenth-edition/
Kumar A, Gangwar R, Zargar AA, Kumar R, Sharma A. Prevalence of diabetes in India: A review of IDF Diabetes
Atlas 10th edition. Curr Diabetes Rev. 2024;20(1):e130423215752. DOI: 10.2174/1573399819666230413094200
Chan LKY, Lin SS, Chan F, Ng DS. Optimizing treatment for diabetic macular edema during cataract surgery. Front
Endocrinol (Lausanne). 2023;14:1106706. DOI: 10.3389/fendo.2023.1106706
Rao H, Jalali JA, Johnston TP, Koulen P. Emerging roles of dyslipidemia and hyperglycemia in diabetic retinopathy:
Molecular mechanisms and clinical perspectives. Front Endocrinol (Lausanne). 2021;12:620045. DOI: 10.3389/
fendo.2021.620045
Park SJ, Park DH. Revisiting lipids in retinal diseases: A focused review on age-related macular degeneration and
diabetic retinopathy. J Lipid Atheroscler. 2020;9(3):406–18. DOI: 10.12997/jla.2020.9.3.406
Xu YX, Pu SD, Zhang YT, Tong XW, Sun XT, Shan YY, et al. Insulin resistance is associated with the presence and
severity of retinopathy in patients with type 2 diabetes. Clin Exp Ophthalmol. 2024;52(1):63–77. DOI: 10.1111/
ceo.14344
Meng C, Xing Y, Huo L, Ma H. Relationship between estimated glucose disposal rate and type 2 diabetic retinopathy.
Diabetes Metab Syndr Obes. 2023;16:807–18. DOI: 10.2147/DMSO.S395818
Behera R, Biswas J, Ray S, Sarkar I, Dey AK. Association of serum lipid profile and body mass index with diabetic
retinopathy in type ii diabetes mellitus – a cross sectional study. Eur J Cardiovasc Med. 2023;13(4):419–24.
Alvi R, Memon MS, Shera S, Mumtaz SN, Shaikh SA, Fahim MF. Visual outcome of laser treatment in diabetic
macular edema: Study from an Urban Diabetes Care Center. Pak J Med Sci. 2016;32(5):1229–33. DOI: 10.12669/
pjms.325.10597
Hellmann F, Verdi M, Schlemper BR Jr, Caponi S. 50th anniversary of the Declaration of Helsinki: The double standard
was introduced. Arch Med Res. 2014;45(7):600–1. DOI: 10.1016/j.arcmed.2014.10.005
Luxmi S, Ritika M, Lubna A, Pragati G, Lal BB. Diabetic macular edema and its association to systemic risk factors in an
urban north Indian population. J Clin Ophthalmol. 2018;2(2):86–91. DOI: 10.35841/clinical-ophthalmology.2.2.86-91
Graue-Hernandez EO, Rivera-De-La-Parra D, Hernandez-Jimenez S, Aguilar-Salinas CA, Kershenobich-Stalnikowitz
D, Jimenez-Corona A. Prevalence and associated risk factors of diabetic retinopathy and macular oedema in
patients recently diagnosed with type 2 diabetes. BMJ Open Ophthalmol. 2020;5(1):e000304. DOI: 10.1136/
bmjophth-2019-000304
Raman R, Rani PK, Kulothungan V, Rachepalle SR, Kumaramanickavel G, Sharma T. Influence of serum lipids on
clinically significant versus nonclinically significant macular edema: SN-DREAMS Report number 13. Ophthalmology.
;117(4):766–72. DOI: 10.1016/j.ophtha.2009.09.005
Feng L, Nian S, Tong Z, Zhu Y, Li Y, Zhang C, et al. Age-related trends in lipid levels: A large-scale cross-sectional
study of the general Chinese population. BMJ Open. 2020;10(3):e034226. DOI: 10.1136/bmjopen-2019-034226
Kamoi K, Takeda K, Hashimoto K, Tanaka R, Okuyama S. Identifying risk factors for clinically significant
diabetic macula edema in patients with type 2 diabetes mellitus. Curr Diabetes Rev. 2013;9(3):209–17.
DOI: 10.2174/1573399811309030002
Martín-Merino E, Fortuny J, Rivero-Ferrer E, Lind M, Garcia-Rodriguez LA. Risk factors for diabetic macular
oedema in type 2 diabetes: A case-control study in a United Kingdom primary care setting. Prim Care Diabetes.
;11(3):288–96. DOI: 10.1016/j.pcd.2017.03.002
Romero-Aroca P, Baget-Bernaldiz M, Fernandez-Ballart J, Plana-Gil N, Soler-Lluis N, Mendez-Marin I, et al. Tenyear incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes.
Diabetes Res Clin Pract. 2011;94(1):126–32. DOI: 10.1016/j.diabres.2011.07.004
Prakash GS, Kothari M. Risk factors associated with clinically significant macular edema in patients with type 2
diabetes mellitus. Int J Sci Stud. 2016;3(12):120–4.
Vivsiana I, Marushchak M. Does the lipid profile depend on the comorbidity of overweight/obesity and arterial
hypertension in patients with type 2 diabetes mellitus? Bull Med Biol Res. 2021;3(3):5–11. DOI: 10.11603/bmbr.2706-
2021.3.12560
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Luxmi Singh, Meghna Sootinck, Zaman Beg, Bharti Nigam, Anu Chandra
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
